Beam Therapeutics BEAM 深 沪
已收盘 09-26 16:00:00 美东时间
22.97
-0.120
-0.52%
华盛通- 最 高23.4343
- 今 开23.17
- 成交量 198.42万股
- 最 低 22.53
- 昨 收 23.09
- 总市值 23.20亿
- 52周最高 35.25
- 市盈率 静 --
- 换手率 1.96%
- 52周最低 13.525
- 委 比 5.87%
- 总股本 1.01亿
- 历史最高 138.522
- 量 比 0.87
- 振 幅 3.92%
- 历史最低 13.00
- 每 手 1
- 风险率 4.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Is Beam Therapeutics Gaining or Losing Market Support?
Beam Therapeutics's (NYSE:BEAM) short interest as a percent of float has fallen...
09-22 22:01
Will Beam Therapeutics (NASDAQ:BEAM) Spend Its Cash Wisely?
We can readily understand why investors are attracted to unprofitable companies...
09-17 19:00
美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
HC Wainwright & Co. Reiterates Buy on Beam Therapeutics, Maintains $80 Price Target
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Beam Therapeutics (NASDAQ:BEAM) with a Buy and maintains $80 price target.
09-15 19:41
Beamr to Demonstrate Live 4K Quality Enhancement with NVIDIA Holoscan for Media
Beamr Imaging Ltd. will present a real-time AI-powered solution at IBC 2025 in Amsterdam that enhances low-resolution live content to 4K, reducing CDN costs by up to 50%. The solution combines NVIDIA Holoscan for Media with Beamr's CABR technology, offering efficient video optimization. The demonstration will showcase real-time upscaling of 720p content to 4K with AI quality enhancement and optimized distribution. Beamr invites attendees to visit...
09-08 11:00
美股牛股 | 绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%
绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%，美参议院议员敦促特朗普政府暂缓出售公司股份>>
09-04 17:12
U.S. General Services Administration Renews Beam Global Contract Through 2030
SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Beam Global announced the renewal of its Multiple Award Schedule (MAS) contract with the U.S. General Services Administration (GSA) through October 31, 2030, with options to extend until 2040. Beam Global's offerings have been added to Special Item Number (SIN) 334512, enabling state and local governments to purchase its products through the GSA MAS program, streamlining procurement processes and elimi...
08-26 10:00
What Does the Market Think About Beam Therapeutics?
Beam Therapeutics's (NYSE:BEAM) short percent of float has risen 4.04% since it...
08-25 22:01
Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences
Beam Therapeutics Inc. announced that its management will participate in fireside chats at three upcoming investor conferences: Citi’s 2025 Biopharma Back to School Conference on September 3, 2025, Wells Fargo Healthcare Conference on September 4, 2025, and H.C. Wainwright’s 27th Global Investment Conference on September 8, 2025. Live webcasts will be available on the company’s website, www.beamtx.com, and archived for 60 days. Beam Therapeutics ...
08-25 11:00
Beamr to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Beamr Imaging Ltd. (NASDAQ: BMR), a leading video optimization company, will present virtually at the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-11, 2025. Investors and professionals can register and schedule one-on-one meetings on September 11. Beamr’s on-demand presentation will be available on the conference website from September 5, 2025, until December 4, 2025. The company, trusted by Netflix and Para...
08-21 11:00
